{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T12:46:36Z","timestamp":1785847596961,"version":"3.56.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":28,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005743","name":"Universit\u00e0 Cattolica del Sacro Cuore","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005743","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Assisted Reproductive Technologies (ART) have become nowadays a cornerstone in the management of infertility. While these treatments are generally considered safe, concerns have been raised regarding their potential influence on breast cancer (BC) risk, particularly in specific subgroups of women.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This narrative review aims to evaluate the most relevant past and current literature on the association between ART-related hormonal treatments and breast cancer risk, highlighting potential biological mechanisms, epidemiological evidence, and clinical implications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A literature search was conducted through PubMed, focusing on medium-to-large cohort and case-control studies, meta-analyses, and guidelines published to date. Evidence was synthesized by distinguishing overall ART\/IVF risk estimates from drug-specific findings and subgroup-specific risk modifiers. Particular attention was given to the most recent or most comprehensive reports when multiple publications were derived from the same cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>To date, current evidence does not support a real and consistent overall increase in breast cancer risk following ART-related hormonal treatments. Large population-based studies and recent meta-analyses are generally reassuring, particularly when ART-treated women are compared with infertile untreated women rather than with the general population. Some studies report modest risk elevations in selected subgroups, including nulliparous or nulligravid women, women undergoing repeated or high-dose stimulation cycles, and women with hereditary BC predisposition; however, these findings are inconsistent and often limited by residual confounding, small subgroup numbers, and incomplete dose information. Progesterone supplementation appears safe in the context of ART, with no consistent evidence of increased BC risk. Gonadotropins, including hMG, may transiently increase estrogen exposure, but large-scale studies and meta-analyses generally do not confirm a long-term increase in breast cancer incidence.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10549-026-08036-x","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T15:47:59Z","timestamp":1785340079000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Assisted Reproductive Technologies (ART) and breast cancer risk: hormonal treatments under the spotlight"],"prefix":"10.1007","volume":"218","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0309-034X","authenticated-orcid":false,"given":"Cristiana","family":"Boldrini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3368-1684","authenticated-orcid":false,"given":"Micol","family":"Bottalico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca L.","family":"Lia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5095-6009","authenticated-orcid":false,"given":"Valentina","family":"Longo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-3198-1465","authenticated-orcid":false,"given":"Silvia","family":"Gigli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,29]]},"reference":[{"key":"8036_CR1","unstructured":"World Health Organization (WHO) (2023) Infertility prevalence estimates, 1990-2021. World Health Organization, Geneva. ISBN 978-920068315"},{"issue":"4","key":"8036_CR2","doi-asserted-by":"publisher","first-page":"hoac051","DOI":"10.1093\/hropen\/hoac051","volume":"2022","author":"CM Cox","year":"2022","unstructured":"Cox CM, Thoma ME, Tchangalova N, Mburu G, Bornstein MJ, Johnson CL, Kiarie J (2022) Infertility prevalence and the methods of estimation from 1990 to 2021: a systematic review and meta-analysis. Hum Reprod Open 2022(4):hoac051. https:\/\/doi.org\/10.1093\/hropen\/hoac051","journal-title":"Hum Reprod Open"},{"key":"8036_CR3","unstructured":"ESHRE (European Society of Human Reproduction and Embryology) (Data sources vary, commonly updated). Factsheet on infertility - prevalence, treatment and fertility decline in Europe. https:\/\/www.eshre.eu\/Guidelines-and-Legal"},{"issue":"1","key":"8036_CR4","doi-asserted-by":"publisher","first-page":"22","DOI":"10.7326\/M18-1323","volume":"170","author":"HB Nichols","year":"2019","unstructured":"Nichols HB, Schoemaker MJ, Cai J, Xu J, Wright LB, Brook MN, Jones ME, Adami HO, Baglietto L, Bertrand KA, Blot WJ, Boutron-Ruault MC, Dorronsoro M, Dossus L, Eliassen AH, Giles GG, Gram IT, Hankinson SE, Hoffman-Bolton J, Kaaks R, Key TJ, Kitahara CM, Larsson SC, Linet M, Merritt MA, Milne RL, Pala V, Palmer JR, Peeters PH, Riboli E, Sund M, Tamimi RM, Tj\u00f8nneland A, Trichopoulou A, Ursin G, Vatten L, Visvanathan K, Weiderpass E, Wolk A, Zheng W et al (2019) Breast cancer risk after recent childbirth: a pooled analysis of 15 prospective studies. Ann Intern Med 170(1):22\u201330. https:\/\/doi.org\/10.7326\/M18-1323. Epub 11 Dec 2018. PMID: 30534999; PMCID: PMC6760671","journal-title":"Ann Intern Med"},{"issue":"9","key":"8036_CR5","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1158\/1055-9965.EPI-11-0465","volume":"20","author":"JR Palmer","year":"2011","unstructured":"Palmer JR, Boggs DA, Wise LA, Ambrosone CB, Adams-Campbell LL, Rosenberg L (2011) Parity and lactation in relation to estrogen receptor negative breast cancer in African American women. Cancer Epidemiol Biomarker Prev 20(9):1883\u20131891. https:\/\/doi.org\/10.1158\/1055-9965.EPI-11-0465 [PubMed:21846820]","journal-title":"Cancer Epidemiol Biomarker Prev"},{"issue":"9","key":"8036_CR6","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1158\/1055-9965.EPI-17-0246","volume":"26","author":"HB Nichols","year":"2017","unstructured":"Nichols HB, Schoemaker MJ, Wright LB, McGowan C, Brook MN, McClain KM et al (2017) The premenopausal breast cancer collaboration: a pooling project of studies participating in the National Cancer Institute Cohort Consortium. Cancer Epidemiol Biomarker Prev 26(9):1360\u20131369. https:\/\/doi.org\/10.1158\/1055-9965.EPI-17-0246","journal-title":"Cancer Epidemiol Biomarker Prev"},{"issue":"22","key":"8036_CR7","doi-asserted-by":"publisher","first-page":"8042","DOI":"10.26355\/eurrev_201811_16434","volume":"22","author":"L Del Pup","year":"2018","unstructured":"Del Pup L, Peccatori FA, Levi-Setti PE, Codacci-Pisanelli G, Patrizio P (2018) Risk of cancer after assisted reproduction: a review of the available evidences and guidance to fertility counselors. Eur Rev Med Pharmacol Sci 22(22):8042\u20138059. https:\/\/doi.org\/10.26355\/eurrev_201811_16434","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"12","key":"8036_CR8","first-page":"1435","volume":"127","author":"MM Reigstad","year":"2020","unstructured":"Reigstad MM et al (2020) Fertility drugs and cancer risk: a systematic review and meta-analysis of cohort studies. BJOG: Int J Obstet Gynaecol 127(12):1435\u20131447","journal-title":"BJOG: Int J Obstet Gynaecol"},{"issue":"2","key":"8036_CR9","first-page":"438","volume":"107","author":"I Hjorth","year":"2017","unstructured":"Hjorth I et al (2017) Cancer risk among women treated with fertility drugs: a population-based cohort study. Fertil Steril 107(2):438\u2013444","journal-title":"Fertil Steril"},{"key":"8036_CR10","first-page":"156","volume":"126","author":"I Hjorth","year":"2020","unstructured":"Hjorth I et al (2020) Infertility, in vitro fertilization and breast cancer: a systematic review and meta-analysis. Eur J Cancer 126:156\u2013165","journal-title":"Eur J Cancer"},{"issue":"5","key":"8036_CR11","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.clbc.2018.03.003","volume":"18","author":"R Taheripanah","year":"2018","unstructured":"Taheripanah R, Balash F, Anbiaee R, Mahmoodi M, Akbari Sene A (2018) Breast cancer and ovulation induction treatments. Clin Breast Cancer 18(5):395\u2013399. https:\/\/doi.org\/10.1016\/j.clbc.2018.03.003. Epub 15 Mar 2018","journal-title":"Clin Breast Cancer"},{"issue":"25","key":"8036_CR12","first-page":"1","volume":"23","author":"A Chandra","year":"2005","unstructured":"Chandra A, Martinez GM, Mosher WD, Abma JC, Jones J (2005) Fertility, family planning, and reproductive health of U.S. women: data from the 2002 national survey of family growth. Vital Health Stat 23(25):1\u2013160. PMID: 16532609","journal-title":"Vital Health Stat"},{"key":"8036_CR13","doi-asserted-by":"publisher","unstructured":"Practice Committee of the American Society for Reproductive Medicine (2004) Use of clomiphene citrate in women. Fertil Steril 82(suppl 1):S90\u2013S96. https:\/\/doi.org\/10.1016\/j.fertnstert.2004.05.008","DOI":"10.1016\/j.fertnstert.2004.05.008"},{"key":"8036_CR14","doi-asserted-by":"publisher","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hr\u00f3bjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https:\/\/doi.org\/10.1136\/bmj.n71. PMID: 33782057","DOI":"10.1136\/bmj.n71"},{"issue":"9190","key":"8036_CR15","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1016\/S0140-6736(99)05203-4","volume":"354","author":"A Venn","year":"1999","unstructured":"Venn A, Watson L, Bruinsma F, Giles G, Healy D (1999) Risk of cancer after use of fertility drugs with in-vitro fertilisation. Lancet 354(9190):1586\u20131590. https:\/\/doi.org\/10.1016\/S0140-6736(99)05203-4. PMID: 10560672","journal-title":"Lancet"},{"key":"8036_CR16","doi-asserted-by":"publisher","first-page":"k2644","DOI":"10.1136\/bmj.k2644","volume":"362","author":"CL Williams","year":"2018","unstructured":"Williams CL, Jones ME, Swerdlow AJ, Botting BJ, Davies MC, Jacobs I et al (2018) Risks of ovarian, breast, and corpus uteri cancer in women treated with assisted reproductive technology in Great Britain, 1991-2010: data linkage study including 2.2 million person years of observation. BMJ 362:k2644. https:\/\/doi.org\/10.1136\/bmj.k2644","journal-title":"BMJ"},{"issue":"3","key":"8036_CR17","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.21873\/invivo.12391","volume":"35","author":"M Diakosavvas","year":"2021","unstructured":"Diakosavvas M, Fasoulakis Z, Ntounis T, Koutras A, Angelou K, Tsatsaris G, Syllaios A, Garmpis N, Kontomanolis EN (2021) A potential pathogenic link between cancer of female reproductive system and infertile women treated with assisted reproduction techniques. In Vivo 35(3):1393\u20131399. https:\/\/doi.org\/10.21873\/invivo.12391. Epub 28 Apr 2021. PMID: 33910816; PMCID: PMC8193339","journal-title":"In Vivo"},{"issue":"12","key":"8036_CR18","doi-asserted-by":"publisher","first-page":"3152","DOI":"10.1093\/humrep\/deab219","volume":"36","author":"D Vassard","year":"2021","unstructured":"Vassard D, Pinborg A, Kamper-J\u00f8rgensen M, Lyng Forman J, Glazer CH, Kroman N, Schmidt L (2021) Assisted reproductive technology treatment and risk of breast cancer: a population-based cohort study. Hum Reprod 36(12):3152\u20133160. https:\/\/doi.org\/10.1093\/humrep\/deab219. PMID: 34580714","journal-title":"Hum Reprod"},{"issue":"6","key":"8036_CR19","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1093\/jbi\/wbac049","volume":"4","author":"SA Furlong","year":"2022","unstructured":"Furlong SA, Sauerbrun-Cutler MT, Dibble EH, Carpentier B (2022) Fertility treatments and breast cancer: a significant risk for our patients? J Breast Imag 4(6):568\u2013581. https:\/\/doi.org\/10.1093\/jbi\/wbac049. PMID: 38416995","journal-title":"J Breast Imag"},{"key":"8036_CR20","doi-asserted-by":"publisher","first-page":"986477","DOI":"10.3389\/fendo.2022.986477","volume":"13","author":"X Liu","year":"2022","unstructured":"Liu X, Yue J, Pervaiz R, Zhang H, Wang L (2022) Association between fertility treatments and breast cancer risk in women with a family history or BRCA mutations: a systematic review and meta-analysis. Front Endocrinol 13:986477. https:\/\/doi.org\/10.3389\/fendo.2022.986477","journal-title":"Front Endocrinol"},{"issue":"3","key":"8036_CR21","doi-asserted-by":"publisher","first-page":"73","DOI":"10.22551\/2024.44.1103.10292","volume":"11","author":"AM Mihai","year":"2024","unstructured":"Mihai AM, Ianculescu LM, Cre\u021boiu D (2024 Oct 9) In vitro fertilization impact on the risk of breast cancer. Arch Clin Cases 11(3):73\u201382. https:\/\/doi.org\/10.22551\/2024.44.1103.10292. PMID: 39479256; PMCID: PMC11520175","journal-title":"Arch Clin Cases"},{"key":"8036_CR22","doi-asserted-by":"publisher","first-page":"104320","DOI":"10.1016\/j.critrevonc.2024.104320","volume":"197","author":"C Chen","year":"2024","unstructured":"Chen C, Shi H, Yang J, Bao X, Sun Y (2024) The risk of breast cancer and gynecologic malignancies after ovarian stimulation: meta-analysis of cohort study. Crit Rev Oncol Hematol 197:104320. https:\/\/doi.org\/10.1016\/j.critrevonc.2024.104320. Epub 11 Mar 2024. PMID: 38479585","journal-title":"Crit Rev Oncol Hematol"},{"key":"8036_CR23","doi-asserted-by":"publisher","unstructured":"Hughes E, Collins J, Vandekerckhove P (2000) Clomiphene citrate for unexplained subfertility in women. Cochrane Database Syst Rev (2): CD000057. https:\/\/doi.org\/10.1002\/14651858.CD000057","DOI":"10.1002\/14651858.CD000057"},{"issue":"2","key":"8036_CR24","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s10549-006-9238-4","volume":"100","author":"L Lerner-Geva","year":"2006","unstructured":"Lerner-Geva L, Keinan-Boker L, Blumstein T et al (2006) Infertility, ovulation induction treatments and the incidence of breast cancer\u2014a historical prospective cohort of Israeli women. Breast Cancer Res Treat 100(2):201\u2013212. https:\/\/doi.org\/10.1007\/s10549-006-9238-4","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"8036_CR25","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/S0015-0282(99)00085-0","volume":"71","author":"G Potashnik","year":"1999","unstructured":"Potashnik G, Lerner-Geva L, Genkin L et al (1999) Fertility drugs and the risk of breast and ovarian cancers: results of a long-term follow-up study. Fertil Steril 71(5):853\u2013859. https:\/\/doi.org\/10.1016\/S0015-0282(99)00085-0","journal-title":"Fertil Steril"},{"issue":"7","key":"8036_CR26","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1158\/1055-9965.EPI-07-0075","volume":"16","author":"A Jensen","year":"2007","unstructured":"Jensen A, Sharif H, Svare EI et al (2007) Risk of breast cancer after exposure to fertility drugs: results from a large Danish cohort study. Cancer Epidemiol Biomarker Prev 16(7):1400\u20131407","journal-title":"Cancer Epidemiol Biomarker Prev"},{"issue":"3","key":"8036_CR27","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/aje\/kwn318","volume":"169","author":"R Calderon-Margalit","year":"2008","unstructured":"Calderon-Margalit R, Friedlander Y, Yanetz R, Kleinhaus K, Perrin MC, Manor O, Harlap S, Paltiel O (2008) Cancer risk after exposure to treatments for ovulation induction. Am J Epidemiol 169(3):365\u2013375. https:\/\/doi.org\/10.1093\/aje\/kwn318. Epub 26 Nov 2008","journal-title":"Am J Epidemiol"},{"issue":"2","key":"8036_CR28","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/s0015-0282(01)02986-7","volume":"77","author":"J Dor","year":"2002","unstructured":"Dor J, Lerner-Geva L, Rabinovici J, Chetrit A, Levran D, Lunenfeld B, Mashiach S, Modan B (2002 Feb) Cancer incidence in one cohort of infertile women, who underwent in vitro fertilization. Fertil Steril 77(2):324\u2013327. https:\/\/doi.org\/10.1016\/s0015-0282(01)02986-7","journal-title":"Fertil Steril"},{"issue":"9","key":"8036_CR29","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1093\/humrep\/deh371","volume":"19","author":"LA Brinton","year":"2004","unstructured":"Brinton LA, Scoccia B, Moghissi KS et al (2004) Breast cancer risk associated with ovulation-stimulating drugs. Hum Reprod 19(9):2005\u20132013","journal-title":"Hum Reprod"},{"issue":"9","key":"8036_CR30","doi-asserted-by":"publisher","first-page":"3671","DOI":"10.1210\/en.2002-220228","volume":"143","author":"EL Milliken","year":"2002","unstructured":"Milliken EL, Ameduri RK, Landis MD, Behrooz A, AbdulKarim FW, Keri RA (2002) Ovarian hyperstimulation by LH leads to mammary gland hyperplasia and cancer predisposition in transgenic mice. Endocrinol 143(9):3671\u20133680. https:\/\/doi.org\/10.1210\/en.2002-220228","journal-title":"Endocrinol"},{"key":"8036_CR31","doi-asserted-by":"publisher","unstructured":"Messina MJ, Loprinzi CL (2001) Soy for breast cancer survivors: a critical review of the literature. J Nutr 131(11):3095S\u20133108S. https:\/\/doi.org\/10.1093\/jn\/131.11.3095S","DOI":"10.1093\/jn\/131.11.3095S"},{"issue":"4","key":"8036_CR32","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/S0015-0282(02)04950-6","volume":"79","author":"RT Burkman","year":"2003","unstructured":"Burkman RT, Tang MTC, Malone KE, Marchbanks PA, McDonald JA, Folger SG (2003) Infertility drugs and the risk of breast cancer: findings from the National Institute of Child Health and Human Development women\u2019s contraceptive and reproductive experiences study. Fertil Steril 79(4):844\u2013851. https:\/\/doi.org\/10.1016\/S0015-0282(02)04950-6","journal-title":"Fertil Steril"},{"issue":"4","key":"8036_CR33","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1158\/1055-9965.EPI-13-0996","volume":"23","author":"LA Brinton","year":"2014","unstructured":"Brinton LA, Scoccia B, Moghissi KS, Westhoff CL, Niwa S, Ruggieri D, Trabert B, Lamb EJ (2014) Long-term relationship of ovulation-stimulating drugs to breast cancer risk. Cancer Epidemiol Biomarker Prev 23(4):584\u2013593. https:\/\/doi.org\/10.1158\/1055-9965.EPI-13-0996","journal-title":"Cancer Epidemiol Biomarker Prev"},{"issue":"1","key":"8036_CR34","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.fertnstert.2021.01.044","volume":"116","author":"Y Beebeejaun","year":"2021","unstructured":"Beebeejaun Y, Athithan A, Copeland TP, Kamath MS, Sarris I, Sunkara SK (2021) Risk of breast cancer in women treated with ovarian stimulation drugs for infertility: a systematic review and meta-analysis. Fertil Steril 116(1):198\u2013207. https:\/\/doi.org\/10.1016\/j.fertnstert.2021.01.044","journal-title":"Fertil Steril"},{"issue":"1","key":"8036_CR35","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12964-024-01516-x","volume":"22","author":"X Lu","year":"2024","unstructured":"Lu X, Mao J, Qian C et al (2024) High estrogen during ovarian stimulation induced loss of maternal imprinted methylation that is essential for placental development via overexpression of TET2 in mouse oocytes. Cell Commun Signal 22(1):135. https:\/\/doi.org\/10.1186\/s12964-024-01516-x","journal-title":"Cell Commun Signal"},{"issue":"12","key":"8036_CR36","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1158\/1055-9965.EPI-19-0652","volume":"28","author":"S Guleria","year":"2019","unstructured":"Guleria S, Kj\u00e6r SK, Albieri V, Frederiksen K, Jensen A (2019) A cohort study of breast cancer risk after 20 years of follow-up of women treated with fertility drugs. Cancer Epidemiol Biomarker Prev 28(12):1986\u20131992. https:\/\/doi.org\/10.1158\/1055-9965.EPI-19-0652","journal-title":"Cancer Epidemiol Biomarker Prev"},{"issue":"1","key":"8036_CR37","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1093\/humupd\/dmt034","volume":"20","author":"TN Sergentanis","year":"2014","unstructured":"Sergentanis TN, Diamantaras AA, Perlepe C, Kanavidis P, Skalkidou A, Petridou E (2014) IVF and breast cancer: a systematic review and meta-analysis. Hum Reprod Update 20(1):106\u2013123. https:\/\/doi.org\/10.1093\/humupd\/dmt034","journal-title":"Hum Reprod Update"},{"key":"8036_CR38","doi-asserted-by":"publisher","unstructured":"Cullinane C, Gillan H, Geraghty J, Evoy D, Rothwell J, McCartan D, McDermott EW, Prichard RS (2022) Fertility treatment and breast-cancer incidence: meta-analysis. BJS Open 6(1). https:\/\/doi.org\/10.1093\/bjsopen\/zrab149","DOI":"10.1093\/bjsopen\/zrab149"},{"issue":"10","key":"8036_CR39","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1093\/humrep\/deh422","volume":"19","author":"E Gauthier","year":"2004","unstructured":"Gauthier E, Paoletti X, Clavel-Chapelon F (2004) Breast cancer risk associated with being treated for infertility: results from the French E3N cohort study. Hum Reprod 19(10):2216\u20132221. https:\/\/doi.org\/10.1093\/humrep\/deh422","journal-title":"Hum Reprod"},{"issue":"10","key":"8036_CR40","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1007\/s10552-008-9175-0","volume":"19","author":"J Kotsopoulos","year":"2008","unstructured":"Kotsopoulos J, Librach CL, Lubinski J, Gronwald J, Kim-Sing C, Ghadirian P, Lynch HT, Moller P, Foulkes WD, Randall S, Manoukian S, Pasini B, Tung N, Ainsworth PJ, Cummings S, Sun P, Narod SA (2008) Hereditary breast cancer clinical study group. Infertility, treatment of infertility, and the risk of breast cancer among women with BRCA1 and BRCA2 mutations: a case-control study. Cancer Causes Control 19(10):1111\u20131119. https:\/\/doi.org\/10.1007\/s10552-008-9175-0","journal-title":"Cancer Causes Control"},{"issue":"1","key":"8036_CR41","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s10549-010-1140-4","volume":"124","author":"TG Zreik","year":"2010","unstructured":"Zreik TG, Mazloom A, Chen Y et al (2010) Fertility drugs and the risk of breast cancer: a meta-analysis and review. Breast Cancer Res Treat 124(1):13\u201326. https:\/\/doi.org\/10.1007\/s10549-010-1140-4","journal-title":"Breast Cancer Res Treat"},{"key":"8036_CR42","doi-asserted-by":"publisher","unstructured":"Org\u00e9as CC, Sanner K, Hall P et al (2009) Breast cancer incidence after hormonal infertility treatment in Sweden: a cohort study. Am J Obstet Gynecol 200(1):e72.1\u2013e72.7. https:\/\/doi.org\/10.1016\/j.ajog.2008.08.066","DOI":"10.1016\/j.ajog.2008.08.066"},{"issue":"15","key":"8036_CR43","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1093\/jnci\/82.15.1286","volume":"82","author":"IH Russo","year":"1990","unstructured":"Russo IH, Koszalka M, Russo J (1990 Aug 1) Human chorionic gonadotropin and rat mammary cancer prevention. J Natl Cancer Inst 82(15):1286\u20131289. https:\/\/doi.org\/10.1093\/jnci\/82.15.1286. PMID: 2115592","journal-title":"J Natl Cancer Inst"},{"key":"8036_CR44","unstructured":"Zhang J, Liu H, Wang Y, Mao X, Chen Q (2023) Factors affecting implantation: what really matters? Global Reprod Health 8(1). Retrieved from https:\/\/journals.lww.com\/grh"},{"key":"8036_CR45","doi-asserted-by":"publisher","unstructured":"Van der Linden M, Buckingham K, Farquhar C, Kremer JA, Metwally M (2015) Luteal phase support for assisted reproduction cycles. Cochrane Database Systematic Rev 2016(10):CD009154. https:\/\/doi.org\/10.1002\/14651858.CD009154.pub3","DOI":"10.1002\/14651858.CD009154.pub3"},{"issue":"6","key":"8036_CR46","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1093\/humupd\/dmm021","volume":"13","author":"HM Fatemi","year":"2007","unstructured":"Fatemi HM, Popovic-Todorovic B, Papanikolaou E, Donoso P, Devroey P (2007) An update of luteal phase support in stimulated IVF cycles. Hum Reproduction Update 13(6):581\u2013590. https:\/\/doi.org\/10.1093\/humupd\/dmm021","journal-title":"Hum Reproduction Update"},{"issue":"22","key":"8036_CR47","doi-asserted-by":"publisher","first-page":"14138","DOI":"10.3390\/ijms232214138","volume":"23","author":"C Bulletti","year":"2022","unstructured":"Bulletti C, Bulletti FM, Sciorio R, Guido M (2022) Progesterone: the key factor of the beginning of life. Int J Mol Sci 23(22):14138. https:\/\/doi.org\/10.3390\/ijms232214138. PMID: 36430614; PMCID: PMC9692968","journal-title":"Int J Mol Sci"},{"issue":"6","key":"8036_CR48","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1016\/j.fertnstert.2021.07.002","volume":"116","author":"P Melo","year":"2021","unstructured":"Melo P, Chung Y, Pickering O, Price MJ, Fishel S, Khairy M, Kingsland C, Lowe P, Petsas G, Rajkhowa M, Sephton V, Tozer A, Wood S, Labarta E, Wilcox M, Devall A, Gallos I, Coomarasamy A (2021) Serum luteal phase progesterone in women undergoing frozen embryo transfer in assisted conception: a systematic review and meta-analysis. Fertil Steril 116(6):1534\u20131556. https:\/\/doi.org\/10.1016\/j.fertnstert.2021.07.002. Epub 10 Aug 2021","journal-title":"Fertil Steril"},{"issue":"3","key":"8036_CR49","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41574-023-00921-5","volume":"20","author":"A Garg","year":"2024","unstructured":"Garg A, Zielinska AP, Yeung AC, Abdelmalak R, Chen R, Hossain A, Israni A, Nelson SM, Babwah AV, Dhillo WS, Abbara A (2024 Mar) Luteal phase support in assisted reproductive technology. Nat Rev Endocrinol 20(3):149\u2013167. https:\/\/doi.org\/10.1038\/s41574-023-00921-5. Epub 18 Dec 2023. PMID: 38110672","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"8036_CR50","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.maturitas.2014.07.009","volume":"79","author":"X Ruan","year":"2014","unstructured":"Ruan X, Mueck AO (2014) Systemic progesterone therapy\u2014oral, vaginal, injections and even transdermal? Maturitas 79(3):248\u2013255. https:\/\/doi.org\/10.1016\/j.maturitas.2014.07.009. Epub 22 Jul 2014. PMID: 25113944","journal-title":"Maturitas"},{"issue":"Suppl S161","key":"8036_CR51","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/aogs.12770","volume":"94","author":"W Ciampaglia","year":"2015","unstructured":"Ciampaglia W, Cognigni GE (2015) Clinical use of progesterone in infertility and assisted reproduction. Acta Obstet Gynecol Scand 94(S161):17\u201327. https:\/\/doi.org\/10.1111\/aogs.12770. PMID: 26345161","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"1","key":"8036_CR52","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s43032-023-01302-z","volume":"31","author":"A Patki","year":"2024","unstructured":"Patki A (2024) Role of dydrogesterone for luteal phase support in assisted reproduction. Reprod Sci 31(1):17\u201329. https:\/\/doi.org\/10.1007\/s43032-023-01302-z. Epub 24 Jul 2023. PMID: 37488405","journal-title":"Reprod Sci"},{"key":"8036_CR53","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.bpobgyn.2020.05.005","volume":"69","author":"E Labarta","year":"2020","unstructured":"Labarta E, Rodr\u00edguez C (2020) Progesterone use in assisted reproductive technology. Best Pract Res Clin Obstet Gynaecol 69:74\u201384. https:\/\/doi.org\/10.1016\/j.bpobgyn.2020.05.005. Epub 4 Jun 2020. PMID: 32616441","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"Suppl S161","key":"8036_CR54","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/aogs.12771","volume":"94","author":"S Taraborrelli","year":"2015","unstructured":"Taraborrelli S (2015) Physiology, production and action of progesterone. Acta Obstet Gynecol Scand 94(S161):8\u201316. https:\/\/doi.org\/10.1111\/aogs.12771. PMID: 26358238","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"1","key":"8036_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12672-020-00379-1","volume":"11","author":"N Sathyamoorthy","year":"2020","unstructured":"Sathyamoorthy N, Lange CA (2020) Progesterone and breast cancer: an NCI workshop report. Horm Cancer 11(1):1\u201312. https:\/\/doi.org\/10.1007\/s12672-020-00379-1. PMID: 32016820","journal-title":"Horm Cancer"},{"issue":"6","key":"8036_CR56","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/nrc3518","volume":"13","author":"C Brisken","year":"2013","unstructured":"Brisken C (2013) Progesterone signalling in breast cancer: a neglected hormone coming into the limelight. Nat Rev Cancer 13(6):385\u2013396. https:\/\/doi.org\/10.1038\/nrc3518","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"8036_CR57","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1042\/EBC20200163","volume":"65","author":"S Giulianelli","year":"2021","unstructured":"Giulianelli S, Lamb CA, Lanari C (2021) Progesterone receptors in normal breast development and breast cancer. Essays Biochem 65(6):951\u2013969. https:\/\/doi.org\/10.1042\/EBC20200163. PMID: 34061163","journal-title":"Essays Biochem"},{"issue":"4","key":"8036_CR58","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1093\/humrep\/deaa293","volume":"36","author":"JF Barcroft","year":"2021","unstructured":"Barcroft JF, Galazis N, Jones BP, Getreu N, Bracewell-Milnes T, Grewal KJ, Sorbi F, Yazbek J, Lathouras K, Smith JR, Hardiman P, Thum MY, Ben-Nagi J, Ghaem-Maghami S, Verbakel J, Saso S (2021) Fertility treatment and cancers\u2014the eternal conundrum: a systematic review and meta-analysis. Hum Reprod 36(4):1093\u20131107. https:\/\/doi.org\/10.1093\/humrep\/deaa293","journal-title":"Hum Reprod"},{"key":"8036_CR59","unstructured":"American Society for Reproductive Medicine (2024) Fertility drugs and cancer: a guideline. ASRM Practice Committee. Retrieved from https:\/\/prod.asrm.org\/practice-guidance\/practice-committee-documents\/fertility-drugs-and-cancer-a-guideline-2024\/"},{"key":"8036_CR60","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ejogrb.2013.11.009","volume":"173","author":"M Kasum","year":"2014","unstructured":"Kasum M, Beketi\u0107-Ore\u0161kovi\u0107 L, Peddi PF, Ore\u0161kovi\u0107 S, Johnson RH (2014) Fertility after breast cancer treatment. Eur J Obstet Gynecol Reprod Biol 173:13\u201318. https:\/\/doi.org\/10.1016\/j.ejogrb.2013.11.009. Epub 17 Nov 2013. PMID: 24315568","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"29","key":"8036_CR61","doi-asserted-by":"publisher","first-page":"3293","DOI":"10.1200\/JCO.21.00535","volume":"39","author":"M Lambertini","year":"2021","unstructured":"Lambertini M, Blondeaux E, Bruzzone M, Perachino M, Anderson RA, de Azambuja E, Poorvu PD, Kim HJ, Villarreal-Garza C, Pistilli B, Vaz-Luis I, Saura C, Ruddy KJ, Franzoi MA, Sertoli C, Ceppi M, Azim HA Jr, Amant F, Demeestere I, Del Mastro L, Partridge AH, Pagani O, Peccatori FA (2021) Pregnancy after breast cancer: a systematic review and meta-analysis. J Clin Oncol 39(29):3293\u20133305. https:\/\/doi.org\/10.1200\/JCO.21.00535. Epub 1 Jul 2021. PMID: 34197218","journal-title":"J Clin Oncol"},{"issue":"9","key":"8036_CR62","doi-asserted-by":"publisher","first-page":"3295","DOI":"10.1210\/jc.2008-0938","volume":"93","author":"KB Horwitz","year":"2008","unstructured":"Horwitz KB, Sartorius CA (2008) Progestins in hormone replacement therapies reactivate cancer stem cells in women with pre-existing breast cancers: a hypothesis. J Clin Endocr Metab 93(9):3295\u20133298. https:\/\/doi.org\/10.1210\/jc.2008-0938","journal-title":"Jour Clin Endocr Metab"},{"issue":"9","key":"8036_CR63","doi-asserted-by":"publisher","first-page":"3295","DOI":"10.1210\/jc.2008-0938","volume":"93","author":"KB Horwitz","year":"2008","unstructured":"Horwitz KB, Sartorius CA (2008 Sep) Progestins in hormone replacement therapies reactivate cancer stem cells in women with preexisting breast cancers: a hypothesis. J Clin Endocrinol Metab 93(9):3295\u20133298. https:\/\/doi.org\/10.1210\/jc.2008-0938. Epub 22 Jul 2008. PMID: 18647813; PMCID: PMC2567860","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"8036_CR64","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1016\/j.fertnstert.2007.09.001","volume":"90","author":"T Perri","year":"2008","unstructured":"Perri T, Aizer A, Ben-Baruch N, Ashkenazi J, Weisz B, Shapira M (2008) Fertility treatments and the risk of breast cancer in BRCA mutation carriers: a case-control study. Fertil Steril 90(6):1826\u20131831. https:\/\/doi.org\/10.1016\/j.fertnstert.2007.09.001","journal-title":"Fertil Steril"},{"key":"8036_CR65","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.ejca.2020.04.013","volume":"133","author":"S Paluch-Shimon","year":"2020","unstructured":"Paluch-Shimon S, Cardoso F, Partridge AH, Abulafia MP, Azim HA, Cardoso MJ (2020) Use of fertility preservation and ovarian stimulation in BRCA-mutated breast cancer patients: a systematic review. Eur J Cancer 133:218\u2013228. https:\/\/doi.org\/10.1016\/j.ejca.2020.04.013","journal-title":"Eur J Cancer"},{"issue":"7","key":"8036_CR66","doi-asserted-by":"publisher","first-page":"4008","DOI":"10.1210\/jc.2003-031924","volume":"89","author":"PA Mote","year":"2004","unstructured":"Mote PA, Leary JA, Avery KA, Sandelin K, Chenevix-Trench G (2004) Germ-line mutations in BRCA1 or BRCA2 in the normal breast are associated with altered expression of estrogen-responsive proteins and the predominance of progesterone receptor A. J Clin Endocr Metab 89(7):4008\u20134014. https:\/\/doi.org\/10.1210\/jc.2003-031924","journal-title":"Jour Clin Endocr Metab"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-026-08036-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-026-08036-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-026-08036-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T11:54:18Z","timestamp":1785844458000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-026-08036-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":66,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["8036"],"URL":"https:\/\/doi.org\/10.1007\/s10549-026-08036-x","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"5 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"24"}}